| Heart disease and stroke statistics—2016 update: a report from the American Heart Association D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ... circulation 133 (4), e38-e360, 2016 | 68937* | 2016 |
| Apixaban versus warfarin in patients with atrial fibrillation CB Granger, JH Alexander, JJV McMurray, RD Lopes, EM Hylek, ... New England Journal of Medicine 365 (11), 981-992, 2011 | 11389 | 2011 |
| 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task … PT O'gara, FG Kushner, DD Ascheim, DE Casey, MK Chung, ... Journal of the American college of cardiology 61 (4), e78-e140, 2013 | 10665* | 2013 |
| Fourth universal definition of myocardial infarction (2018) K Thygesen, JS Alpert, AS Jaffe, BR Chaitman, JJ Bax, DA Morrow, ... Circulation 138 (20), e618-e651, 2018 | 9970 | 2018 |
| 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation developed … Authors/Task Force Members, AJ Camm, GYH Lip, R De Caterina, ... European heart journal 33 (21), 2719-2747, 2012 | 6665 | 2012 |
| 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology … SM Al-Khatib, WG Stevenson, MJ Ackerman, WJ Bryant, DJ Callans, ... Journal of the American College of Cardiology 72 (14), e91-e220, 2018 | 4352 | 2018 |
| Fundamentals of clinical trials LM Friedman, CD Furberg, DL DeMets, DM Reboussin, CB Granger springer, 2015 | 4278 | 2015 |
| Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial S Yusuf, MA Pfeffer, K Swedberg, CB Granger, P Held, JJV McMurray, ... The Lancet 362 (9386), 777-781, 2003 | 3865 | 2003 |
| Predictors of hospital mortality in the global registry of acute coronary events CB Granger, RJ Goldberg, O Dabbous, KS Pieper, KA Eagle, CP Cannon, ... Archives of internal medicine 163 (19), 2345-2353, 2003 | 3162 | 2003 |
| 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American … GN Levine, ER Bates, JA Bittl, RG Brindis, SD Fihn, LA Fleisher, ... Circulation 134 (10), e123-e155, 2016 | 3098 | 2016 |
| Spironolactone for heart failure with preserved ejection fraction B Pitt, MA Pfeffer, SF Assmann, R Boineau, IS Anand, B Claggett, ... New England Journal of Medicine 370 (15), 1383-1392, 2014 | 2900 | 2014 |
| Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial JJV McMurray, J Östergren, K Swedberg, CB Granger, P Held, ... The Lancet 362 (9386), 767-771, 2003 | 2690 | 2003 |
| Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM … CB Granger, JJV McMurray, S Yusuf, P Held, EL Michelson, B Olofsson, ... The Lancet 362 (9386), 772-776, 2003 | 2664 | 2003 |
| Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme MA Pfeffer, K Swedberg, CB Granger, P Held, JJV McMurray, ... The Lancet 362 (9386), 759-766, 2003 | 2664 | 2003 |
| A comprehensive 1000 Genomes–based genome-wide association meta-analysis of coronary artery disease Nature genetics 47 (10), 1121-1130, 2015 | 2625 | 2015 |
| A randomized trial of therapies for type 2 diabetes and coronary artery disease BARI 2D Study Group New England Journal of Medicine 360 (24), 2503-2515, 2009 | 2280 | 2009 |
| Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE) KAA Fox, OH Dabbous, RJ Goldberg, KS Pieper, KA Eagle, F Van de Werf, ... bmj 333 (7578), 1091, 2006 | 2191 | 2006 |
| A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry KA Eagle, MJ Lim, OH Dabbous, KS Pieper, RJ Goldberg, F Van de Werf, ... Jama 291 (22), 2727-2733, 2004 | 2181 | 2004 |
| The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction GUSTO Angiographic Investigators New England Journal of Medicine 329 (22), 1615-1622, 1993 | 2154 | 1993 |
| Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization Epilog Investigators New England Journal of Medicine 336 (24), 1689-1697, 1997 | 2139 | 1997 |
Paul W Armstrongprofessor medicine university albertaZweryfikowany adres z ualberta.ca